Observational studyRheumatology international2026
Endoplasmic reticulum stress and apoptosis-associated biomarkers in rheumatoid arthritis: an exploratory case-control study.
Observational study in Rheumatology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent synovial inflammation and progressive joint destruction, leading to functional disability and reduced quality of life. Beyond classical inflammatory pathways, increasing evidence indicates that endoplasmic reticulum (ER) stress and activation of the unfolded protein response (UPR) contribute to immune dysregulation and chronic inflammation in RA. However, the clinical relevance of circulating ER stress-related biomarkers in RA remains insufficiently defined. This study aimed to evaluate serum levels of ER stress-related and apoptosis-associated markers in patients with RA, to assess their ability to discriminate RA from healthy individuals, and to explore their associations with inflammatory parameters and disease activity. This observational case-control study was conducted between 2021 and 2022 at the Rheumatology Clinic of Sivas Cumhuriyet University Faculty of Medicine Hospital. This observational case-control study included 35 patients with RA and 31 age- and sex-matched healthy controls. Serum levels of GRP78, eIF2α, ATF4, CHOP, caspase-3, and caspase-9 were measured using enzyme-linked immunosorbent assay. Disease activity was assessed using the Disease Activity Score-28 (DAS28). Statistical analyses included group comparisons, receiver operating characteristic curve analysis, and Spearman correlation analyses. A total of 67 participants (35 RA, 32 controls) were included. GRP-78, ATF4, eIF2α, caspase-3, and caspase-9 levels were significantly higher in RA patients (all p < 0.01), whereas CHOP levels were comparable between groups (p = 0.103). Caspase-3 demonstrated the highest discriminatory performance (AUC = 0.774, 95% CI: 0.656-0.891; p < 0.001). Caspase-3 and caspase-9 remained independently associated with RA in multivariable analysis. No significant correlations were observed between ER stress markers and DAS28 scores. Circulating ER stress-related apoptotic markers, particularly caspase-3 and caspase-9, were found to be associated with rheumatoid arthritis and may represent exploratory candidate biomarker signals reflecting the potential involvement of ER stress-apoptosis pathways in disease pathophysiology.
Indexed as
Identifiers
42443563What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.